NO20034322D0 - Behandling av demens og neurodegenerative sykdommer med intermediate doserav LHRH-antagonister - Google Patents
Behandling av demens og neurodegenerative sykdommer med intermediate doserav LHRH-antagonisterInfo
- Publication number
- NO20034322D0 NO20034322D0 NO20034322A NO20034322A NO20034322D0 NO 20034322 D0 NO20034322 D0 NO 20034322D0 NO 20034322 A NO20034322 A NO 20034322A NO 20034322 A NO20034322 A NO 20034322A NO 20034322 D0 NO20034322 D0 NO 20034322D0
- Authority
- NO
- Norway
- Prior art keywords
- dementia
- treatment
- neurodegenerative diseases
- lhrh antagonists
- intermediate doses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28743401P | 2001-04-30 | 2001-04-30 | |
| PCT/EP2002/004677 WO2002102401A1 (en) | 2001-04-30 | 2002-04-27 | Treatment of dementia and neurodegenerative diseases with intermediate doses of lhrh antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20034322L NO20034322L (no) | 2003-09-26 |
| NO20034322D0 true NO20034322D0 (no) | 2003-09-26 |
Family
ID=23102886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20034322A NO20034322D0 (no) | 2001-04-30 | 2003-09-26 | Behandling av demens og neurodegenerative sykdommer med intermediate doserav LHRH-antagonister |
Country Status (27)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6828415B2 (en) * | 1993-02-19 | 2004-12-07 | Zentaris Gmbh | Oligopeptide lyophilisate, their preparation and use |
| US20020077327A1 (en) * | 1999-09-23 | 2002-06-20 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| US6960591B2 (en) | 2000-07-05 | 2005-11-01 | Yamanouchi Pharmaceutical Co., Ltd. | Propane-1,3-dione derivative |
| DE10137174A1 (de) * | 2001-07-31 | 2003-02-13 | Zentaris Ag | Verwendung von LHRH-Antagonisten in nichtkastrierenden Dosen zur Verbesserung der T-Zellen-vermittelten Immunität |
| AU2005250273B2 (en) | 2004-06-04 | 2010-10-14 | Astellas Pharma Inc. | Propane-1,3-dione derivative or its salt |
| CA2590997A1 (en) * | 2004-12-23 | 2006-07-06 | Voyager Pharmaceutical Corporation | Leuprolide acetate and acetylcholinesterase inhibitors or nmda receptor antagonists for the treatment of alzheimer`s disease |
| US20080171736A1 (en) * | 2004-12-23 | 2008-07-17 | Gregory Christopher W | Treatment of Alzheimer's Disease and Mild Cognitive impairment using GnRH-I analogs and one or more of acetylcholinesterase inhibitors and NMDA receptor antagonists |
| BRPI0609625A2 (pt) * | 2005-03-31 | 2010-04-20 | Astellas Pharma Inc | derivados de propano-1,3-diona ou sal destes |
| MX2009004140A (es) * | 2006-10-21 | 2009-07-10 | Abbott Gmbh & Co Kg | Compuestos heterociclicos y su uso como inhibidores de la glucogeno sintasa quinasa 3. |
| RU2010113966A (ru) * | 2007-09-11 | 2011-10-20 | Мондобайотек Лабораториз Аг (Li) | Применение меланотропинстимулирующего фактора в качестве терапевтического средства |
| RU2010114033A (ru) * | 2007-09-11 | 2011-10-20 | Мондобайотек Лабораториз Аг (Li) | Применение ингибитора nf-каппа в sn50 и необязательно ангиотензина iii в качестве терапевтических средств при лечении, например, инфекции hbv |
| EP2095818A1 (en) | 2008-02-29 | 2009-09-02 | AEterna Zentaris GmbH | Use of LHRH antagonists at non-castrating doses |
| EP2307040B1 (en) * | 2008-05-29 | 2015-09-09 | Isr Immune System Regulation Ab | Use of gnrh and sex hormones for treating viral disease, in particular hiv/aids |
| MX336726B (es) | 2010-09-27 | 2016-01-27 | Abbott Gmbh & Co Kg | Compuestos heterociclicos y su uso como inhibidores de la glucogeno sintasa quinasa-3. |
| US9090592B2 (en) | 2010-12-30 | 2015-07-28 | AbbVie Deutschland GmbH & Co. KG | Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors |
| EP3560555A1 (en) * | 2018-04-26 | 2019-10-30 | LifeArc | A composition for treating one or more estrogen related diseases |
| WO2025155903A1 (en) * | 2024-01-19 | 2025-07-24 | Temple University-Of The Commonwealth System Of Higher Education | Compositions of antioxidant translation modulators for treating neurodegenerative disorders |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3135743A (en) * | 1960-06-29 | 1964-06-02 | Sterling Drug Inc | Steroido[2. 3-d]isoxazoles and preparation thereof |
| CA2254769A1 (en) * | 1996-05-20 | 1997-11-27 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| DE19911771B4 (de) * | 1999-03-17 | 2006-03-30 | Zentaris Gmbh | LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung |
| EP1185530A1 (en) * | 1999-05-14 | 2002-03-13 | Neurocrine Biosciences, Inc. | Imidazo- and pyrrolo[1,2-a]pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists |
| CA2309395A1 (en) * | 1999-06-04 | 2000-12-04 | Richard Lloyd Bowen | Methods for preventing and treating alzheimer's disease |
| ES2249302T3 (es) * | 1999-10-15 | 2006-04-01 | Neurocrine Biosciences, Inc. | Antagonistas del receptor de la hormona liberadora de gonadotropina y sus metodos de uso relacionados. |
| CA2406832A1 (en) | 2000-04-13 | 2002-10-10 | Takeda Chemical Industries, Ltd. | Preventives/remedies for alzheimer's disease |
| US6960591B2 (en) | 2000-07-05 | 2005-11-01 | Yamanouchi Pharmaceutical Co., Ltd. | Propane-1,3-dione derivative |
-
2002
- 2002-04-27 KR KR10-2003-7014128A patent/KR20040000446A/ko not_active Ceased
- 2002-04-27 AU AU2002310788A patent/AU2002310788B2/en not_active Ceased
- 2002-04-27 BR BR0209290-5A patent/BR0209290A/pt not_active IP Right Cessation
- 2002-04-27 US US10/133,967 patent/US7288517B2/en not_active Expired - Fee Related
- 2002-04-27 AT AT02735312T patent/ATE400287T1/de not_active IP Right Cessation
- 2002-04-27 SK SK1451-2003A patent/SK14512003A3/sk unknown
- 2002-04-27 PT PT02735312T patent/PT1392348E/pt unknown
- 2002-04-27 CA CA002444876A patent/CA2444876A1/en not_active Abandoned
- 2002-04-27 IL IL15677702A patent/IL156777A0/xx unknown
- 2002-04-27 DK DK02735312T patent/DK1392348T3/da active
- 2002-04-27 EP EP02735312A patent/EP1392348B1/en not_active Expired - Lifetime
- 2002-04-27 WO PCT/EP2002/004677 patent/WO2002102401A1/en not_active Ceased
- 2002-04-27 CZ CZ20033167A patent/CZ20033167A3/cs unknown
- 2002-04-27 CN CNB028042964A patent/CN1317030C/zh not_active Expired - Fee Related
- 2002-04-27 NZ NZ544417A patent/NZ544417A/en unknown
- 2002-04-27 MX MXPA03008666A patent/MXPA03008666A/es active IP Right Grant
- 2002-04-27 SI SI200230730T patent/SI1392348T1/sl unknown
- 2002-04-27 RU RU2003134949/14A patent/RU2319501C2/ru not_active IP Right Cessation
- 2002-04-27 ES ES02735312T patent/ES2307760T3/es not_active Expired - Lifetime
- 2002-04-27 HU HU0400067A patent/HUP0400067A2/hu unknown
- 2002-04-27 DE DE60227507T patent/DE60227507D1/de not_active Expired - Fee Related
- 2002-04-27 JP JP2003504987A patent/JP2004529207A/ja not_active Withdrawn
- 2002-04-27 PL PL36231902A patent/PL362319A1/xx not_active Application Discontinuation
- 2002-04-27 UA UA2003109180A patent/UA80679C2/uk unknown
-
2003
- 2003-07-10 ZA ZA200305326A patent/ZA200305326B/xx unknown
- 2003-09-26 NO NO20034322A patent/NO20034322D0/no not_active Application Discontinuation
- 2003-11-10 BG BG108339A patent/BG108339A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1392348E (pt) | 2008-09-09 |
| ATE400287T1 (de) | 2008-07-15 |
| HUP0400067A2 (hu) | 2004-04-28 |
| US7288517B2 (en) | 2007-10-30 |
| NO20034322L (no) | 2003-09-26 |
| JP2004529207A (ja) | 2004-09-24 |
| PL362319A1 (en) | 2004-10-18 |
| NZ544417A (en) | 2008-03-28 |
| ZA200305326B (en) | 2003-07-30 |
| EP1392348A1 (en) | 2004-03-03 |
| EP1392348B1 (en) | 2008-07-09 |
| DE60227507D1 (de) | 2008-08-21 |
| CZ20033167A3 (cs) | 2004-08-18 |
| WO2002102401A1 (en) | 2002-12-27 |
| RU2319501C2 (ru) | 2008-03-20 |
| RU2003134949A (ru) | 2005-02-10 |
| MXPA03008666A (es) | 2004-10-15 |
| KR20040000446A (ko) | 2004-01-03 |
| AU2002310788B2 (en) | 2007-04-05 |
| IL156777A0 (en) | 2004-02-08 |
| CA2444876A1 (en) | 2002-12-27 |
| CN1317030C (zh) | 2007-05-23 |
| BG108339A (bg) | 2004-11-30 |
| BR0209290A (pt) | 2004-07-13 |
| CN1575185A (zh) | 2005-02-02 |
| UA80679C2 (en) | 2007-10-25 |
| US20020177556A1 (en) | 2002-11-28 |
| DK1392348T3 (da) | 2008-09-29 |
| SI1392348T1 (sl) | 2008-12-31 |
| HK1072000A1 (en) | 2005-08-12 |
| ES2307760T3 (es) | 2008-12-01 |
| SK14512003A3 (sk) | 2004-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20034322L (no) | Behandling av demens og neurodegenerative sykdommer med intermediate doserav LHRH-antagonister | |
| TR200001608T2 (tr) | Amiloidojenik hastalığın önlenmesi ve tedavisi | |
| NO20022531D0 (no) | Vaksine for forebyggelse og behandling av Alzheimer og amyloidrelaterte sykdommer | |
| LU92854I2 (fr) | Combinaison de rilpivirine ou une forme thérapeutique équivalente qui en dérive telle que protégé par le brevet de base, tel qu'un sel pharmaceutiquement acceptable de rilpivirine, incluant le sel chlorhydrate de rilpivirine, et ténofovir, en particulier le fumarate de ténofovir disoproxil | |
| LTPA2015001I1 (lt) | Tioflavino dariniai ir jų panaudojimas Alzhaimerio ligos diagnostikai ir terapijai | |
| GB0223040D0 (en) | Therapeutic compounds | |
| WO2002002506A8 (en) | Compounds to treat alzheimer's disease | |
| NO20026199L (no) | Forbindelser for behandling av Alzheimers sykdom | |
| DE69736441D1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
| EA200400352A1 (ru) | Органолептически приемлемые распадающиеся во рту композиции | |
| EA200401114A2 (ru) | Замещённые гидроксиэтиламины | |
| EA200301223A1 (ru) | Лекарственные формы окскарбазепина | |
| DE60144514D1 (de) | Verwendung von il-18 inhibitoren | |
| JO2207B1 (en) | Pharmaceutical radiological compounds to diagnose Alzheimer's disease | |
| EA200800880A1 (ru) | Комбинация росиглитазона и донепезила, предназначенная для улучшения когнитивной функции | |
| NO20000771D0 (no) | Anvendelse av fankinon for behandling av Alzheimers sykdom | |
| DE60028928D1 (de) | Verwendung von angiotensin ii rezeptorantagonisten zur behandlung von akutem myokardischen infarkt | |
| BR0000486A (pt) | Antagonistas do neuropeptìdeo y | |
| NO20053341D0 (no) | Hindring og behandling av Alzheimers sykdom. | |
| SE0002353D0 (sv) | New use | |
| MXPA03008406A (es) | Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos y agentes antagonistas de endotelina. | |
| EE200300394A (et) | GlyT-1 inhibiitorid | |
| HK1063639A (en) | Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases | |
| AU2002319451A1 (en) | Therapeutic strategies for prevention and treatment of alzheimer's disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |